Synapse Biomedical
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Synapse Biomedical sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Synapse Biomedical: 4 sponsored US clinical trials, none currently recruiting.
Synapse Biomedical sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is Amyotrophic Lateral Sclerosis (ALS), with 1 trials.
Upper-quartile sponsor footprint
Synapse Biomedical sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation
NCT04309123
Clinical Study to Investigate Safety and Performance of TransLoc Electrodes in Patients Undergoing Surgical Procedures
NCT02410798
Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis
NCT01605006
Electrical Activation of The Diaphragm for Ventilatory Assist
NCT00010374
Therapeutic Areas
How the Synapse Biomedical archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Amyotrophic Lateral Sclerosis (ALS) (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Synapse Biomedical: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Synapse Biomedical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Synapse Biomedical page
4 registered trials is a research-attention snapshot, not an endorsement of Synapse Biomedical or any single study.
- None of Synapse Biomedical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Amyotrophic Lateral Sclerosis (ALS) is the condition Synapse Biomedical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Amyotrophic Lateral Sclerosis (ALS) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Synapse Biomedical pipeline card: 4 registered trials from official public datasets.Report a data error.